Book chapters

Elsevier,

Encyclopedia of Inland Waters, Second Edition, Volume 4, 2022, Pages 47-57

This chapter advances SDG goals 6 and 11 by focussing on Kenya's inland, coastal and marine resources, and their associated stressors and threats to ecological integrity. It provides key recommendations to promote societal benefits and enhance sustainable management of these aquatic resources.
Elsevier,

Encyclopedia of Inland Waters, Second Edition, Volume 4, 2022, Pages 47-57

This chapters advances SDG goals 11 and 12 by highlighting the pressures posed by agricultural activities to inland water systems. It discusses each of the pressures considering the trade-offs between productivity and environmental impacts.
Elsevier,

Encyclopedia of Inland Waters, Second Edition, 2022, pp 450-463

This chapter aligns with Goal 11: Sustainable Cities and Communities and 6: Clean Water and Sanitation by reviewing Kenya's inland, coastal and marine resources, their associated stressors and key recommendations to promote societal benefits and enhance sustainable management of these aquatic resources.
Elsevier,

Julia Derx, Rita Linke, Domenico Savio, Monica Emelko, Philip Schmidt, Jack Schijven, Liping Pang, Regina Sommer, Margaret Stevenson, Harold van den Berg, Saskia Rutjes, Andreas H. Farnleitner, Alfred Paul Blaschke, From Groundwater to Drinking Water – Current Approaches for Microbial Monitoring and Risk Assessment in Porous Aquifers, Encyclopedia of Inland Waters (Second Edition), Elsevier, 2022, Pages 580-594, ISBN 9780128220412

This chapter supports SDG 6 by summarizing the current approaches for evaluating pathogen fate and transport in the environment, their removal during subsurface transport in porous aquifers and the needed infection protection to achieve safe drinking water.

Neurobiology of Brain Disorders (Second Edition), Biological Basis of Neurological and Psychiatric Disorders, 2022, Pages 313-336

This book chapter advances SDG #3 and #10 by reviewing several key topics that influence our understanding of pathogenic mechanisms and lead to the identification of novel therapeutic strategies. These include the diagnostic spectrum of MCI and AD, genetic risk alleles associated with late-onset AD, structures of gamma-secretase and tau, imaging and fluid biomarkers, the role of microglia and neuroinflammation, and novel animal models of AD.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 481-500

This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by examining how various pathogens cause a variety of central nervous system (CNS) dysfunctions and the mechanisms of these changes.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 147-164

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing the most recent scientific advances that have improved diagnostic abilities and showcasing experimental studies of gene therapy and conventional pharmacological treatments to lead to effective treatment of these hereditary disorders.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 233-251

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by highlighting amyotrophic lateral sclerosis (ALS), a neurodegenerative disease of the motor system characterized by focal and then generalized weakness leading to paralysis and death from respiratory failure.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 275-292

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on the clinical features, ethics, and neurobiology of HD and the exciting approaches being employed today to advance understanding of underlying mechanisms in an effort to develop therapies that would delay the onset and slow progression of this disease.
Elsevier,

Principles and Practice of Pediatric Infectious Diseases (Sixth Edition)
2023, Pages 1237-1243.e3

This content supports the SDG Goal 3: Good health and well-being by discussing the pathogens, epidemiology, clniical manifestations, laboratory findings, treatment and prevention of Hepatitis A.

Pages